Sujal M. Patel - 09 Jun 2021 Form 3 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Anna Mowry, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
3
Filing time
09 Jun 2021, 21:38:37 UTC
Next filing
02 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NAUT Common Stock 9,614,388 09 Jun 2021 Direct
holding NAUT Common Stock 5,280,476 09 Jun 2021 By PFV I, LLC F1
holding NAUT Common Stock 1,814,035 09 Jun 2021 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAUT Stock Option (Right to Buy) 09 Jun 2021 Common Stock 788,833 $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
F2 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F3 Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 31, 2021.

Remarks:

Exhibit 24: Power of Attorney